Are there primary peritoneal cancer clinical trials in New York?

Yes. We're currently tracking 28 recruiting primary peritoneal cancer studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a primary peritoneal cancer study in New York?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in New York to take part?

Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a primary peritoneal cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · New York

Primary Peritoneal Cancer clinical trials in New York

We’re tracking 28 recruiting primary peritoneal cancer studies with a site in New York — including Phase 1, Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in New York

NCT05564377RecruitingPhase 2
Find targeted cancer treatments using genetic testing
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
Buffalo, New YorkAges Any age
NCT07489287RecruitingPhase 1
GB-5267 for platinum-resistant ovarian, peritoneal, or fallopian tube cancer
This trial tests a new cell therapy (GB-5267) for people with platinum-resistant ovarian, peritoneal, or fallopian tube cancer. It requires multiple tumor biopsies and aims to see if the treatment can help when standard chemo stops working.
Buffalo, New YorkAges 18 years+
NCT07213804RecruitingPhase 3
Study of sofetabart mipitecan for ovarian cancer
This trial tests a new drug called sofetabart mipitecan for people with ovarian cancer that has come back after treatment. It is for those whose cancer is either resistant to platinum chemo (Part A) or sensitive to it (Parts B and C). The study will see if the drug can help shrink or slow the cancer.
Buffalo, New YorkAges 18 years+
NCT07001748RecruitingPhase 2/Phase 3
Testing abdominal chemo plus standard chemo for stomach cancer spread
This trial tests adding the chemotherapy drug paclitaxel directly into the abdomen (intraperitoneal) along with standard IV chemotherapy for people with stomach or gastroesophageal junction cancer that has spread to the lining of the abdomen. The goal is to see if this combination helps control the cancer better than standard treatment alone.
East White Plains, New YorkAges 18 years+

Primary Peritoneal Cancer trials by city in New York

New York

Where these studies are running in New York

Institutions with a site for the recruiting primary peritoneal cancer studies listed above.

Memorial Sloan Kettering Cancer Center · 3 studies
Memorial Sloan Kettering Commack · 2 studies
Memorial Sloan Kettering Westchester · 2 studies
NYU Langone Health · 2 studies
NYU Langone Hospital - Long Island · 2 studies
Roswell Park Cancer Institute · 2 studies
Icahn School of Medicine at Mount Sinai
Memorial Sloan Kettering Nassau

What taking part in a primary peritoneal cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Primary Peritoneal Cancer trials in other states

Common questions

Are there primary peritoneal cancer clinical trials in New York?: Yes. We're currently tracking 28 recruiting primary peritoneal cancer studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a primary peritoneal cancer study in New York?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in New York to take part?: Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a primary peritoneal cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New primary peritoneal cancer studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.